Merck launches tender offer to acquire Terns Pharmaceuticals for $53 per share

April 7, 2026 9:38 AM

Merck & Co (NYSE: MRK) commenced a cash tender offer to purchase all outstanding shares of Terns Pharmaceuticals Inc (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found